|
Back to Home » October 2012 News » Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University |
Correction: Immunovative, Inc. Announces Collaboration With The Robert H. Lurie Compehensive Cancer Center of Northwestern University |
October 06, 2012
NEW YORK, NY--(Marketwire - Oct 6, 2012) - Immunovative, Inc. ("IMUN" or the "Company") (OTCQB: IMUN) announces today that Immunovative Therapies, Ltd. ("ITL") and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University ("Lurie Cancer Center") have agreed to collaborate on the clinical development of its two lead immunotherapy drugs, AlloStimT and AlloVaxT ("Study Drugs").
Source URL: http://www.marketwire.com/mw/release.do?id=1709954&sourceType=3
|
|
|
|
